TIV Dosing Schedules in HIV-infected Pregnant Women

Phase 3, randomised, double-blind trial of trivalent influenza vaccine in influenza (3 arms), sponsored by University of the Witwatersrand. Primary endpoints: Number of participants who mount an adequate immune response one month post vaccination to a double dose compared to single dose of TIV at 1 month, Number of participants who mount an adequate immune response one month post completing vaccination to two-dose TIV administered 1 month apart, compared to single dose TIV and 1 more. Started Sep 2012; status: completed.